14th Jul 2021 15:01
Open Orphan PLC - London-based pharmaceutical services and contract research - Executive Chair Cathal Friel buys 1.1 million shares and Non-Executive Director Brendan Buckley buys 188,679 shares, both at 26.5 pence and worth GBP350,000 in total, on Wednesday. Friel now has 47.1 million shares, a 7.0% stake, while Buckley has 8.0 million shares. Friel says purchases reflect their confidence in "future prospects", noting that investee Poolbeg Pharma PLC will start trading on AIM on Monday next week with a GBP50 million market capitalisation, having raised GBP25 million in its initial public offering.
Current stock price: 26.70p, up 5.7% on Wednesday
Year-to-date change: up 3.5%
By Tom Waite; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
ORPH.L